Environmental enteric dysfunction influences linear growth of children through insulin-like growth factor-1: findings from the Indonesian Action Against Stunting Hub birth cohort
Authors:
- Min Kyaw HtetMHMin Kyaw Htet
- Mifa NurfadilahMNMifa Nurfadilah
- Tiffany C. AngelinTATiffany C. Angelin
- Benjamin Momo KadiaBKBenjamin Momo Kadia
- Isobel L. GabainIGIsobel L. Gabain
- Anouschka S. RamsteijnARAnouschka S. Ramsteijn
- Hilary Davies-KershawHDHilary Davies-Kershaw
- Beatriz Calvo-UrbanoBCBeatriz Calvo-Urbano
- Joanne P. WebsterJWJoanne P. Webster
- Alan W. WalkerAWAlan W. Walker
- Elaine L. FergusonEFElaine L. Ferguson
- Stephen AllenSAStephen Allen
Open Access
- 14 May 2026
- journal article
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 381 (1950)
Abstract
Poor gut health, characterized by persistent immune activation and increased intestinal permeability, is considered a significant underlying cause of impaired child growth. This study aimed to investigate effects of environmental enteric dysfunction (EED) and systemic inflammation on plasma insulin-like growth factor (IGF)-1 and linear growth among Indonesian infants. In this longitudinal cohort study (Action Against Stunting Hub), faecal and plasma samples were collected at six months of age, and anthropometry assessment was conducted at six and twelve months of age. EED markers included faecal myeloperoxidase, alpha-1 antitrypsin and plasma intestinal fatty acid binding protein (IFABP). Systemic inflammation markers included C-reactive protein, alpha-1 acid glycoprotein and cluster of differentiation-14 (CD14). IGF-1 was measured as a growth biomarker. Correlation and multivariable regression analyses assessed association with length-for-age z-score (LAZ). Structural equation modelling explored potential pathways. Elevated EED markers were common among the infants (>80%). Maternal height, birth weight and IGF-1 were significant determinants of LAZ at 12 months. Pathway analysis showed IGF-1 was negatively associated with CD14, whereas CD14 was positively associated with IFABP. EED influences linear growth indirectly through systemic inflammation and altered growth signalling. Studies to further address gut integrity and systemic inflammation to improve linear growth are recommended. This article is part of the theme issue ‘Biological, biomedical and environmental drivers of stunting’.Keywords
Funding Information
- UK Research and Innovation (UKRI) Global Challenges Research Fund (grant number MR/S01313X/1)
This publication has 41 references indexed in Scilit:
- Gut biomolecules (I-FABP, TFF3 and lipocalin-2) are associated with linear growth and biomarkers of environmental enteric dysfunction (EED) in Bangladeshi childrenScientific Reports, 2022
- Circulating FGF21 Levels in Human Health and Metabolic DiseaseExperimental and Clinical Endocrinology & Diabetes, 2019
- FGF19 subfamily members: FGF19 and FGF21Journal of Physiology and Biochemistry, 2019
- Promising Biomarkers of Environmental Enteric Dysfunction: A Prospective Cohort study in Pakistani ChildrenScientific Reports, 2018
- Causal Pathways from Enteropathogens to Environmental Enteropathy: Findings from the MAL-ED Birth Cohort StudyEBioMedicine, 2017
- Improved nutrition in the first 1000 days and adult human capital and healthAmerican Journal of Human Biology, 2017
- Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutritionNutrition, 2017
- Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in BangladeshEBioMedicine, 2015
- Insulin-requiring diabetes in Ethiopia: associations with poverty, early undernutrition and anthropometric disproportionEuropean Journal of Clinical Nutrition, 2010
- Why are nutritionally stunted children at increased risk of obesity? Studies of metabolic rate and fat oxidation in shantytown children from São Paulo, BrazilThe American Journal of Clinical Nutrition, 2000